Rep. David Taylor Unloads Shares of Procter & Gamble Company (The) (NYSE:PG)

Representative David Taylor (Republican-Ohio) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on October 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on October 12th. The trade occurred in the Representative’s “DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)” account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Fifth Third Bancorp (NASDAQ:FITB) on 10/9/2026.
• Purchased $1,001 – $15,000 in shares of RPM International (NYSE:RPM) on 10/9/2026.
• Purchased $1,001 – $15,000 in shares of AT&T (NYSE:T) on 10/9/2026.
• Sold $1,001 – $15,000 in shares of Marathon Petroleum (NYSE:MPC) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Amgen (NASDAQ:AMGN) on 9/22/2026.
• Purchased $1,001 – $15,000 in shares of Installed Building Products (NYSE:IBP) on 9/8/2026.
• Purchased $1,001 – $15,000 in shares of Procter & Gamble (NYSE:PG) on 9/8/2026.
• Sold $1,001 – $15,000 in shares of Amgen (NASDAQ:AMGN) on 8/26/2026.
• Sold $1,001 – $15,000 in shares of Vertex Pharmaceuticals (NASDAQ:VRTX) on 8/26/2026.

Procter & Gamble Stock Performance

NYSE:PG traded up $2.17 during mid-day trading on Friday, hitting $159.25. 13,532,344 shares of the company traded hands, compared to its average volume of 8,482,994. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. Procter & Gamble Company has a one year low of $137.62 and a one year high of $167.25. The firm has a market cap of $369.89 billion, a price-to-earnings ratio of 24.06, a price-to-earnings-growth ratio of 3.90 and a beta of 0.39. The stock’s fifty day moving average price is $146.88 and its 200-day moving average price is $146.52.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. The business had revenue of $21.20 billion during the quarter, compared to analyst estimates of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company’s revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s payout ratio is currently 65.71%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Bank of America cut their target price on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research note on Friday, July 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a research note on Monday, September 21st. Sanford C. Bernstein restated a “market perform” rating and issued a $149.00 price target on shares of Procter & Gamble in a report on Monday, August 24th. JPMorgan Chase & Co. cut their target price on shares of Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating on the stock in a research report on Thursday, July 16th. Finally, Barclays upped their price objective on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $162.20.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Improving U.S. sales outlook: UBS maintained its Buy rating and $172 price target, saying better U.S. sales momentum could help P&G outperform expectations when it reports before the market opens on October 22. Procter & Gamble’s improving US sales trends set up a favorable first-quarter report, UBS says
• Positive Sentiment: Defensive dividend appeal: Recent investor-focused coverage highlighted P&G’s 70-year record of dividend increases. That long history, combined with demand for everyday household products, may support the stock as investors seek stable income and less exposure to technology-sector volatility. Procter & Gamble Has Raised Its Dividend for 70 Years
• Neutral Sentiment: Upcoming earnings are the key catalyst: Analysts expect modest revenue growth for fiscal first-quarter 2027, while the company’s latest reported quarter showed revenue growth of 1.5% year over year and earnings that narrowly exceeded consensus. Investors will focus on organic sales, pricing, volumes and updated full-year guidance. Procter & Gamble Set to Release Earnings
• Negative Sentiment: Profit risks remain: Earnings previews warn that rising costs could pressure margins and cause quarterly earnings to decline, reducing the likelihood of a significant earnings beat. P&G’s valuation—about 24 times earnings based on the supplied data—also leaves less room for disappointment. Procter & Gamble Pre-Q1 Earnings
• Negative Sentiment: Some institutional selling: ETFs were reported as net sellers of PG, a modest near-term technical headwind, though this flow does not necessarily signal a change in the company’s long-term fundamentals. ETFs Are Net Sellers of Procter & Gamble

Insider Buying and Selling

In other news, CFO Andre Schulten sold 3,914 shares of the firm’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the sale, the chief financial officer directly owned 65,618 shares in the company, valued at $9,536,920.12. This trade represents a 5.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc S. Pritchard sold 4,030 shares of Procter & Gamble stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the transaction, the insider owned 187,001 shares of the company’s stock, valued at approximately $26,888,873.79. This represents a 2.11% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 15,135 shares of company stock valued at $2,189,970 in the last ninety days. Company insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Several institutional investors have recently added to or reduced their stakes in the business. James T. Borello RIA acquired a new position in shares of Procter & Gamble in the 3rd quarter valued at $96,000. V Square Quantitative Management LLC boosted its holdings in Procter & Gamble by 5.4% during the third quarter. V Square Quantitative Management LLC now owns 52,286 shares of the company’s stock worth $7,596,000 after buying an additional 2,663 shares in the last quarter. YANKCOM Partnership grew its position in Procter & Gamble by 9.4% during the third quarter. YANKCOM Partnership now owns 13,540 shares of the company’s stock valued at $1,967,000 after buying an additional 1,163 shares during the period. Financial & Tax Architects LLC grew its position in Procter & Gamble by 4.1% during the third quarter. Financial & Tax Architects LLC now owns 50,341 shares of the company’s stock valued at $7,314,000 after buying an additional 1,969 shares during the period. Finally, Comprehensive Financial Consultants Institutional Inc. increased its holdings in Procter & Gamble by 3.4% in the third quarter. Comprehensive Financial Consultants Institutional Inc. now owns 11,361 shares of the company’s stock valued at $1,651,000 after buying an additional 375 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio’s 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Taylor (Republican Party) ran for election to the U.S. House to represent Ohio’s 2nd Congressional District. He won in the general election on November 5, 2024.

David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor’s career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

Procter & Gamble Company Profile

The Procter & Gamble Company (NYSE: PG) is a consumer products company that develops, manufactures and markets branded products used in households and personal care routines. Its portfolio includes products in categories such as beauty, grooming, health care, fabric and home care, and family care.

Major brands associated with Procter & Gamble include Pampers, Tide, Gillette, Head & Shoulders, Pantene, Oral-B, Crest, Olay, Old Spice, Febreze, Mr. Clean, Swiffer and Bounty. The company sells its products through retailers, e-commerce platforms and other distribution channels.

Founded in Cincinnati, Ohio, in 1837 by William Procter and James Gamble, the company has grown into a global consumer goods business serving customers in markets around the world.